TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10678027

Group type: EXPERIMENTAL
Intervention: Primary curative incision
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional incisional drainage
Number of subjects: 100
Study: 8198661

Group type: EXPERIMENTAL
Intervention: Prenatal betamethasone
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Postnatal dexamethasone
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both prenatal betamethasone and postnatal dexamethasone
Number of subjects: 17

Group type: COMPARATOR
Intervention: No corticosteroid treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Adults (control group)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Neonates overall
Number of subjects: 17
Study: 3446157

Group type: EXPERIMENTAL
Intervention: Fructosamine screening
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Glucose screening
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Glucose tolerance tests
Number of subjects: 256
Study: 30219369

Group type: EXPERIMENTAL
Intervention: LeishTec® vaccine (recombinant Leishmania A2 protein, saponin-adjuvanted)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27626285

Group type: EXPERIMENTAL
Intervention: Clinician ratings
Number of subjects: 1460

Group type: EXPERIMENTAL
Intervention: Patient ratings
Number of subjects: 1460

Group type: EXPERIMENTAL
Intervention: Change score definition
Number of subjects: 1460

Group type: EXPERIMENTAL
Intervention: Absolute score definition
Number of subjects: 1460
Study: 24357510

Group type: EXPERIMENTAL
Intervention: Female Sexual Function Index assessments (quarterly)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Sexual inactivity reported quarterly
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Reasons for sexual inactivity (reported n=1663)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Satisfaction with sexual life (reported n=1582)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Satisfaction with sexual life when lack of interest cited (reported n=671)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Interest in learning about treatment for sexual dysfunction
Number of subjects: 125
Study: 23579518

Group type: EXPERIMENTAL
Intervention: Ketamine (supplemented with propofol and alfentanil)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol and alfentanil (supplemented with saline)
Number of subjects: 40
Study: 19804956

Group type: EXPERIMENTAL
Intervention: Low-protein (LP) dietary regimen (protein 0.7 g x kg(‐1) x d(‐1))
Number of subjects: 6

Group type: COMPARATOR
Intervention: Balanced diet (protein 1g x kg(‐1) x d(‐1))
Number of subjects: 6
Study: 18796620

Group type: EXPERIMENTAL
Intervention: Baseline sICAM-1 levels
Number of subjects: 1441
Study: 16803607

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12816915

Group type: EXPERIMENTAL
Intervention: Sampling strategies with samples taken at 10/30/90/240 min
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Sampling strategies with samples taken at 10/30/240 min
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Sampling strategies with samples taken at 10/90/240 min
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Sampling strategies with samples taken at 30/90/240 min
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Sampling strategies with samples taken at 90/240 min
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: One blood sample at 240 min
Number of subjects: 154
Study: 10433305

Group type: EXPERIMENTAL
Intervention: Mild hypothermia therapy (intracranial temperature 34 degrees C) for 48 hours followed by rewarming at 1 degree C per day for 3 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normothermia therapy (intracranial temperature 37 degrees C) for 5 days
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Mild hypothermia therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Normothermia therapy
Number of subjects: 16
Study: 7717819

Group type: EXPERIMENTAL
Intervention: Supine position during submaximal workload (300 kgm.min ± 1)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Upright and recumbent positions during submaximal workload (300 kgm.min ± 1)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Maximal exercise efforts
Number of subjects: 9
Study: 2720131

Group type: EXPERIMENTAL
Intervention: Rectally administered sodium ibuprofen solution
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Rectally administered aluminum ibuprofen suspension
Number of subjects: 8

Group type: COMPARATOR
Intervention: Orally administered ibuprofen solution
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Rectally administered ibuprofen solution
Number of subjects: 8
Study: 1001193

Group type: EXPERIMENTAL
Intervention: Dextran 40 (4 X 500 ml infusions)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control (no dextran)
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Dextran 40
Number of subjects: 192
Study: 31839529

Group type: EXPERIMENTAL
Intervention: Intrathecal laronidase
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no intrathecal laronidase)
Number of subjects: 8
Study: 30391226

Group type: EXPERIMENTAL
Intervention: Intervention group (play-based program enhancing executive function skills)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (focused on dental hygiene, good sleep habits/routines, and physical activity)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Intervention group (inhibitory control assessment)
Number of subjects: 92
Study: 28682422

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP) before operation
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group underwent IABP after invalidation of internal medicine drug treatment
Number of subjects: 84
Study: 25932899

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 24290333

Group type: EXPERIMENTAL
Intervention: Self-managed computer therapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 34
Study: 22480247

Group type: EXPERIMENTAL
Intervention: Bariatric rehabilitation service (BRS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 19196575

Group type: EXPERIMENTAL
Intervention: Epidural anesthesia (EA Group)
Number of subjects: 76

Group type: COMPARATOR
Intervention: General anesthesia (GA Group)
Number of subjects: 76
Study: 17515464

Group type: EXPERIMENTAL
Intervention: BNP > or = 550 pg/mL
Number of subjects: 69

Group type: COMPARATOR
Intervention: BNP < 550 pg/mL
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: BNP > or = 550 pg/mL in patients who underwent valve replacement
Number of subjects: 69

Group type: COMPARATOR
Intervention: BNP < 550 pg/mL in patients who underwent valve replacement
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Truly severe AS
Number of subjects: 69

Group type: COMPARATOR
Intervention: Pseudosevere AS
Number of subjects: 69
Study: 15155424

Group type: EXPERIMENTAL
Intervention: 40 mg methylprednisolone acetate mixed with a short acting local anaesthetic
Number of subjects: 18

Group type: COMPARATOR
Intervention: Short acting local anaesthetic only
Number of subjects: 18
Study: 11275935

Group type: EXPERIMENTAL
Intervention: HIV-infected children
Number of subjects: 280

Group type: COMPARATOR
Intervention: HIV-uninfected children
Number of subjects: 280
Study: 9666011

Group type: EXPERIMENTAL
Intervention: Fluconazole daily (200 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluconazole weekly (400 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluconazole treatment
Number of subjects: 12
Study: 7983583

Group type: EXPERIMENTAL
Intervention: Stress Inoculation Training (SIT) for 20 minutes
Number of subjects: 110

Group type: COMPARATOR
Intervention: Filler condition
Number of subjects: 110
Study: 2955688

Group type: EXPERIMENTAL
Intervention: Reperfusion therapy within 2 hours of symptom onset
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Reperfusion therapy within 3 hours of symptom onset
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Initially patent arteries
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Patent arteries at follow-up
Number of subjects: 46
Study: 31066631

Group type: EXPERIMENTAL
Intervention: Positive expressive writing intervention (writing about a positive memory of the deceased)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Control group (writing about a recent neutral activity)
Number of subjects: 403
Study: 29970054

Group type: EXPERIMENTAL
Intervention: Educational program for nurses and supervisors (two-day workshop, posters, pamphlets on patient safety culture)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Educational program for nurses and supervisors
Number of subjects: 61
Study: 27775830

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 24016864

Group type: EXPERIMENTAL
Intervention: 3 months exercise intervention
Number of subjects: 112

Group type: COMPARATOR
Intervention: 3 months exercise control group
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Combined groups (exercise intervention and control)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Baseline assessment
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Post-intervention assessment
Number of subjects: 112

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 112
Study: 21357578

Group type: EXPERIMENTAL
Intervention: Knee arthroscopy and an 8-week home exercise programme
Number of subjects: 56

Group type: COMPARATOR
Intervention: 8-week home exercise programme only
Number of subjects: 56
Study: 20435181

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg every other day
Number of subjects: 22071

Group type: EXPERIMENTAL
Intervention: Aspirin <150/180 pills/y
Number of subjects: 22071

Group type: EXPERIMENTAL
Intervention: NSAID users >60 days per year
Number of subjects: 22071

Group type: EXPERIMENTAL
Intervention: Aspirin >150/180 pills/y and NSAID users <60 days/y
Number of subjects: 22071

Group type: EXPERIMENTAL
Intervention: Aspirin <150/180 pills/y and NSAID users >60 days/y
Number of subjects: 22071
Study: 19083380

Group type: EXPERIMENTAL
Intervention: Probiotic (Probio‐Stick; containing Lactobacillus acidophilus Rosell‐52 and Bifidobacterium longum Rosell‐175, 3 x 10(9) CFU per sachet stick)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (sensorially identical without probiotics)
Number of subjects: 0
Study: 19694342

Group type: EXPERIMENTAL
Intervention: Enteral diet supplements with arginine and fiber (group I)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Isocaloric, isonitrogenous enteral formula (group II)
Number of subjects: 72
Study: 15191344

Group type: EXPERIMENTAL
Intervention: 5 mg bisoprolol given orally
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy euthyroid controls
Number of subjects: 20
Study: 11313089

Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 9233740

Group type: EXPERIMENTAL
Intervention: Clonidine (0.2 mg orally and a clonidine TTS-3 patch the evening before surgery and 0.3 mg orally on call to the operating room)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 40
Study: 8423228

Group type: EXPERIMENTAL
Intervention: Synthetic human GIP (0.8 pmol/kg.min over 1 h)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Synthetic human GIP (2.4 pmol/kg.min over 1 h)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GLP-1 [7-36 amide] (0.4 pmol/kg.min over 1 h)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GLP-1 [7-36 amide] (1.2 pmol/kg.min over 1 h)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GLP-1 [7-36 amide]
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: GIP
Number of subjects: 18
Study: 3103414

Group type: EXPERIMENTAL
Intervention: Supramaintenance infusion (2.77 +/- 0.2 times fasting M, n = 14)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Submaintenance infusion (1.02 +/- 0.04 times fasting M, n = 6)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Maintenance infusion (1.39 +/- 0.01 times fasting M, n = 20)
Number of subjects: 24
Study: 30738780

Group type: EXPERIMENTAL
Intervention: Radium-223 (55 kBq/kg) plus abiraterone acetate 1000 mg once daily and prednisone or prednisolone 5 mg twice daily
Number of subjects: 806

Group type: COMPARATOR
Intervention: Placebo plus abiraterone acetate 1000 mg once daily and prednisone or prednisolone 5 mg twice daily
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Radium-223
Number of subjects: 806

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 806
Study: 28067719

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Stavudine
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Abacavir (ABC)
Number of subjects: 118

Group type: COMPARATOR
Intervention: All study arms
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Changes in soluble CD163
Number of subjects: 118
Study: 26093743

Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 0
Study: 25146061

Group type: EXPERIMENTAL
Intervention: Royal Jelly (1000 mg capsule taken orally once daily for two consecutive menstrual cycles)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo (capsule taken orally once daily for two consecutive menstrual cycles)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Comparison of Royal Jelly vs Placebo
Number of subjects: 110
Study: 22949478

Group type: EXPERIMENTAL
Intervention: High Framingham Coronary Heart Disease Risk Score (FCRS) (≥20%)
Number of subjects: 3509

Group type: EXPERIMENTAL
Intervention: Known CHD
Number of subjects: 3509

Group type: EXPERIMENTAL
Intervention: High FCRS (≥20%)
Number of subjects: 3509

Group type: COMPARATOR
Intervention: Low/intermediate FCRS (<20%)
Number of subjects: 3509
Study: 19570344

Group type: EXPERIMENTAL
Intervention: Sedation based on BIS monitor (42 cases)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Sedation based on subjective scale SAS (41 cases)
Number of subjects: 83
Study: 17853755

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment group (Yingxiang (LI 20), Shangyingxiang (EX‐HN 8), Yintang (EX‐HN 3), Hegu (LI 4), Fengchi (GB 20), Dazhui (GV 14), Feishu (BL 13))
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group I (Yingxiang (LI 20), Shangyingxiang (EX‐HN 8), Yintang (EX‐HN 3), Hegu (LI 4))
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group II (oral administration of Biyankang tablets, 4 tablets each time, thrice each day)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Cured cases of all groups
Number of subjects: 135
Study: 15056235

Group type: EXPERIMENTAL
Intervention: Inactivated influenza vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (age matched children)
Number of subjects: 0
Study: 11772242

Group type: EXPERIMENTAL
Intervention: Ertapenem at 2 mg/kg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Imipenem at 2 mg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ceftriaxone, cefepime, ceftazidime, cefazolin, cefonicid, cefotaxime, meropenem
Number of subjects: 100
Study: 9389782

Group type: EXPERIMENTAL
Intervention: Peroral oestrogen (2 mg oestradiol valerate tablets)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Transdermal oestradiol gel (1g, 1mg oestradiol)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 79
Study: 7959157

Group type: EXPERIMENTAL
Intervention: Pomeroy's technique with abdominal approach by minilaparotomy and local anesthesia
Number of subjects: 208
Study: 3304783

Group type: EXPERIMENTAL
Intervention: Sulphonylurea therapy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 20
Study: 30348101

Group type: EXPERIMENTAL
Intervention: Tirofiban treatment
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group C1
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control group C2
Number of subjects: 138
Study: 26936891

Group type: EXPERIMENTAL
Intervention: Belimumab plus standard of care (SoC)
Number of subjects: 998

Group type: EXPERIMENTAL
Intervention: Belimumab plus SoC
Number of subjects: 998
Study: 24996592

Group type: COMPARATOR
Intervention: Aerobic exercise for 3 days per week for two weeks (Experiment 1)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Aerobic exercise for 0, 1, 3, or 5 days per week for two weeks (Experiment 2)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Aerobic exercise for 5 days per week for two weeks (Experiment 2)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Aerobic exercise treatment (both experiments)
Number of subjects: 117
Study: 22814420

Group type: EXPERIMENTAL
Intervention: Aspirin challenge (placebo-controlled)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (during aspirin challenge)
Number of subjects: 24
Study: 20881283

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 19031508

Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg/day with alfacalcidol 1 microg/day
Number of subjects: 47

Group type: COMPARATOR
Intervention: Alfacalcidol group (alfacalcidol 1 microg/day alone)
Number of subjects: 47
Study: 16000354

Group type: EXPERIMENTAL
Intervention: Anagrelide plus low-dose aspirin
Number of subjects: 809

Group type: COMPARATOR
Intervention: Hydroxyurea plus low-dose aspirin
Number of subjects: 809
Study: 12197051

Group type: EXPERIMENTAL
Intervention: Prophylactic HPV vaccine based on the marked immunogenicity and safety of the empty viral capsid
Number of subjects: 40000

Group type: COMPARATOR
Intervention: Comparison with another vaccine
Number of subjects: 40000
Study: 10425010

Group type: EXPERIMENTAL
Intervention: Titration group (n = 20) received protamine doses based on heparin concentration measured by the Hepcon system.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (n = 14) received a fixed dose of protamine (3 mg/kg).
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Titration group (n = 20)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 34
Study: 7478713

Group type: EXPERIMENTAL
Intervention: MOR-S (7 min)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: MOR-L (11 min)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: FEN-S (5 min)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: FEN-L (8 min)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Lockout intervals (L and S)
Number of subjects: 78
Study: 2207301

Group type: EXPERIMENTAL
Intervention: Racemic ibuprofen 200 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Racemic ibuprofen 400 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Racemic ibuprofen 800 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Racemic ibuprofen 1200 mg
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Racemic ibuprofen (all doses)
Number of subjects: 4
Study: 6161895

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 13

Group type: COMPARATOR
Intervention: Saralasin
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Captopril in normal subjects
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Captopril in patients with essential hypertension
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Captopril in patients with renovascular hypertension (RVH)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Aprotinin in patients with RVH
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Aprotinin in patients with essential hypertension
Number of subjects: 13
Study: 31044719

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus fluoropyrimidine and cisplatin
Number of subjects: 0
Study: 26945195

Group type: EXPERIMENTAL
Intervention: Telemedicine consultation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Telephone consultation (control)
Number of subjects: 30
Study: 26448791

Group type: EXPERIMENTAL
Intervention: Enhanced CDSS with autism module
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control clinics (no enhanced CDSS module)
Number of subjects: 126
Study: 24176438

Group type: EXPERIMENTAL
Intervention: Zotarolimus-Eluting Endeavor Sprint stent (E-ZES)
Number of subjects: 1600

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 1600
Study: 21128873

Group type: EXPERIMENTAL
Intervention: CBT
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Combination of CBT and Sertraline
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Supportive psychotherapy
Number of subjects: 130
Study: 19417610

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 54

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 54
Study: 17911873

Group type: EXPERIMENTAL
Intervention: Guided dosing within a computerized provider order entry (CPOE) system
Number of subjects: 2981

Group type: COMPARATOR
Intervention: Control group (no guided dosing)
Number of subjects: 2981

Group type: EXPERIMENTAL
Intervention: Guided dosing within a CPOE system
Number of subjects: 2981
Study: 15329426

Group type: EXPERIMENTAL
Intervention: Recombinant surfactant protein C-based surfactant (up to four intratracheal doses within 24 hours)
Number of subjects: 448

Group type: EXPERIMENTAL
Intervention: Standard therapy plus recombinant surfactant protein C-based surfactant
Number of subjects: 448

Group type: COMPARATOR
Intervention: Standard therapy alone
Number of subjects: 448
Study: 11583188

Group type: EXPERIMENTAL
Intervention: Targeted intra-operative radiotherapy (Targit), delivered doses of 5-20 Gy over about 22 min
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional six-week course of radiotherapy
Number of subjects: 25